SCHEMBL15744782

SCHEMBL15744782

CC(C)(C)c1ccc(S(=O)(=O)c2ccc(C(C)(C)C)c(C(C)(C)C)c2)cc1C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 2/20 0.42
MAPT P10636 4/20 0.41
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
GAA P10253 3/20 0.41
ALDH1A1 P00352 6/20 0.39
NR1I2 O75469 1/20 0.38
ELANE P08246 1/20 0.37
PKM P14618 2/20 0.37
HSD11B1 P28845 1/20 0.37
HTR6 P50406 2/20 0.36
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25386985 0.83 ALDH1A1 (0.42) TSHRLMNASMN1; SMN2KDM4EHPGD
SCHEMBL14116999 0.83 GAA (0.43) POLBTSHRMAPK1MAPTLMNA
SCHEMBL7167301 0.82 POLB (0.41) POLBTSHRMAPK1MAPTLMNA
SCHEMBL10788397 0.81 ALDH1A1 (0.55) POLBTSHRMAPTLMNASMN1; SMN2
SCHEMBL5377674 0.81 HTR6 (0.50) POLBTSHRMAPK1MAPTLMNA
SCHEMBL2595702 0.81 ALDH1A1 (0.55) POLBTSHRMAPTLMNASMN1; SMN2
SCHEMBL5527324 0.81 HSD11B1 (0.43) POLBTSHRMAPK1MAPTLMNA
SCHEMBL5520877 0.81 VCAM1 (0.47) POLBTSHRMAPK1MAPTLMNA
SCHEMBL8135299 0.81 MAPT (0.52) POLBTSHRMAPK1MAPTLMNA
SCHEMBL5523223 0.81 POLB (0.38) POLBTSHRMAPK1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773207-B2 Thiol compound, method for synthesizing same, and uses for said thiol compound SHIKOKU CHEMICALS CORPORATION (JP) 2023-10-03 US disclosed
US-9056285-B2 Gas separation membrane CENTRAL GLASS COMPANY, LIMITED (JP) 2015-06-16 US disclosed
US-9050566-B2 Gas separation membrane CENTRAL GLASS COMPANY, LIMITED (JP) 2015-06-09 US disclosed
US-20140144325-A1 Gas Separation Membrane CENTRAL GLASS COMPANY, LIMITED (JP) 2014-05-29 US disclosed
US-20140144324-A1 Gas Separation Membrane CENTRAL GLASS COMPANY, LIMITED (JP) 2014-05-29 US disclosed
US-20140148548-A1 Fluorine-Containing Polymerizable Monomer And Polymer Compound Using Same CENTRAL GLASS COMPANY, LIMITED (JP) 2014-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773207-B2 Thiol compound, method for synthesizing same, and uses for said thiol compound TST, TMT1A, CTH POLB 4373/4885TSHR 3486/4885MAPK1 4198/4885
US-20140148548-A1 Fluorine-Containing Polymerizable Monomer And Polymer Compound Using Same AFF4, AFF2, AFF1 POLB 2934/4885TSHR 1806/4885MAPK1 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.